000			01918 a2200577 4500
005			20250517223005.0
264		0	_c20190903
008			201909s 0 0 eng d
022			_a1872-7980
024	7		_a10.1016/j.canlet.2018.06.012 _2doi
040			_aNLM _beng _cNLM
100	1		_aLan, Linhua
245	0	0	_aDeferoxamine suppresses esophageal squamous cell carcinoma cell growth via ERK1/2 mediated mitochondrial dysfunction. _h[electronic resource]
260			_bCancer letters _c09 2018
300			_a132-143 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aApoptosis
650	0	4	_aCarcinoma, Squamous Cell _xdrug therapy
650	0	4	_aCell Movement
650	0	4	_aCell Proliferation
650	0	4	_aDeferoxamine _xpharmacology
650	0	4	_aEsophageal Neoplasms _xdrug therapy
650	0	4	_aFemale
650	0	4	_aGene Expression Regulation, Neoplastic _xdrug effects
650	0	4	_aHumans
650	0	4	_aMice
650	0	4	_aMice, Nude
650	0	4	_aMitochondria _xdrug effects
650	0	4	_aMitogen-Activated Protein Kinase 1 _xmetabolism
650	0	4	_aMitogen-Activated Protein Kinase 3 _xmetabolism
650	0	4	_aPhosphorylation
650	0	4	_aReactive Oxygen Species _xmetabolism
650	0	4	_aSiderophores _xpharmacology
650	0	4	_aSignal Transduction
650	0	4	_aTumor Cells, Cultured
650	0	4	_aXenograft Model Antitumor Assays
700	1		_aWei, Wei
700	1		_aZheng, Ying
700	1		_aNiu, Lili
700	1		_aChen, Xiaoling
700	1		_aHuang, Dawei
700	1		_aGao, Yang
700	1		_aMo, Shouyong
700	1		_aLu, Jin
700	1		_aGuo, Miaomiao
700	1		_aLiu, Yongzhang
700	1		_aLu, Bin
773	0		_tCancer letters _gvol. 432 _gp. 132-143
856	4	0	_uhttps://doi.org/10.1016/j.canlet.2018.06.012 _zAvailable from publisher's website
999			_c28534138 _d28534138